Company intelligence / Profile preview

Cellaviva

Huddinge, Sweden
Ownership
Private
Employees
~20
Development stage
Other
01

Overview

Cellaviva is Scandinavia's first and largest private stem cell bank, specializing in the collection and preservation of stem cells from umbilical cord blood and tissue. Operating as a subsidiary of NextCell Pharma AB, the company provides families with a long-term storage solution for hematopoietic and mesenchymal stem cells. These cells are stored for potential future use in treating a variety of medical conditions, including blood disorders and immune system diseases. Cellaviva operates under a license from the Swedish Health and Social Care Inspectorate (IVO) and follows strict GMP standards for tissue banking. Their services are designed to empower parents with a biological insurance policy for their children's future health through state-of-the-art cryopreservation technology. The company maintains a strong presence in Sweden and Denmark, serving as a bridge between families and the future of regenerative medicine.

Therapeutic areas
HematologyImmunologyOther
Modalities
Stem cell therapyCell therapy
Industry
Non-Drug Biotech

Beyond the preview

Go deeper on Cellaviva.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellaviva.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call